Schedule 13D ownership disclosure

Applied Therapeutics Inc.

Security class unavailable

Event date: 2020-05-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,394,084
Percent of class
27.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-068461
Form type
SC 13D/A
Filer
Applied Therapeutics, Inc.
CIK
CIK 1697532
Filed
Jun 01, 2020
Reporting period
May 28, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub